Pfizer's long-acting GLP-1 weight loss candidate could set the stage for a stock rally.

The stock has been fairly stable over the past year.

Pfizer Inc. (NYSE:PFE) is included among the Dividend Champions, Contenders, and Challengers List: 15 Highest Yielding Stocks ...

For income investors, there are numerous dividend stocks with strong records, stability and growth potential that can generate wealth for you in the long term.

Pfizer's dividend payout ratio is high, but the company is generated enough free cash flow to cover its dividend. Management remains committed to the dividend program despite Pfizer facing a patent ...

Pfizer's stock has risen off its lows, but remains 50% below its 2021 highs.

Which of the highest-yielding healthcare stocks are value traps or golden opportunities?

A high-yielding payout hasn't been enough reason for investors to buy Pfizer's stock. The pharmaceutical giant's valuation has been cut in half in just three years. Investors appear to be worried ...

Dividend stocks can be a great way to generate passive income. Investors must ensure that companies are generating sufficient free cash flow and earnings to cover their dividends, ideally with the ...

Pfizer appears cheap with a near 7% yield, but capital allocation constraints undermine its investment case. Nearly all of PFE's free cash flow is consumed by dividends, leaving little for buybacks, ...